Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
EDITOR - I wish to address one point from the paper of Seaman et al.
In Australia the drug use in prison is widely accepted as problomatic and
the risk of overdose on release is great.
As a worker in a maximum security prison I have learned of the nature
of drug trafficking in our prison system. At this time a cap of heroin can
be purchased on the street for fifty dollars. However this cap (when it
reaches prison) becomes four caps and sold at fifty dollars each.
A handsome profit and considering the strength of street heroin at
this time not many complaints at the quality so business booms.
With tolerance dropping fairly quickly and finances from those
outside waning, particularly from partners who have many other needs for
the cash tolerance drops quickly.
Upon release a return to a street cap (on the way home in many
instances) leads to a false beleif that 'the old dose is fine'and
overdose follows.
The other concern is that this is almost the perfect murder alabi,
another user got out and o'd, perhaps more common than we think.
Another excellent study from Sheila Gore and her colleages, with a clear message for prevention within prisons. The UK seems capable of producing excellent studies demonstrating the needs, but when will harm reduction activities really start.
The risk of death after release from prison, mainly due to overdoses following loss of tolerance, was already clealy established in a study published in the BMJ 10 years ago(British Medical Journal, vol 297 p.596) to which the authors do not refer.
I would suggest that the editors give prioriy to intervention studies in prisons rather than further research demonstrating health risks associated with imprisonment. Condoms are not yet freely available to prisoners, methadone maintenance (which could reduce dramatically the risk of overdose on release) is provided to only a tiny minority of potential prisoner patients and needle exchange seems a tabou subject.
O.D on Release - A Reality
EDITOR - I wish to address one point from the paper of Seaman et al.
In Australia the drug use in prison is widely accepted as problomatic and
the risk of overdose on release is great.
As a worker in a maximum security prison I have learned of the nature
of drug trafficking in our prison system. At this time a cap of heroin can
be purchased on the street for fifty dollars. However this cap (when it
reaches prison) becomes four caps and sold at fifty dollars each.
A handsome profit and considering the strength of street heroin at
this time not many complaints at the quality so business booms.
With tolerance dropping fairly quickly and finances from those
outside waning, particularly from partners who have many other needs for
the cash tolerance drops quickly.
Upon release a return to a street cap (on the way home in many
instances) leads to a false beleif that 'the old dose is fine'and
overdose follows.
The other concern is that this is almost the perfect murder alabi,
another user got out and o'd, perhaps more common than we think.
Competing interests: No competing interests